Merck Inhales Opportunity: $10B Verona Deal Could Redefine Respiratory Pharma

Unknown Apr 02, 2026 1,350 Views

Pharma giant Merck is reportedly nearing a blockbuster $10 billion deal to acquire Verona Pharma, a clinicalstage respiratory drugmaker, in a move that could reshape its pipeline and market positioning. The Financial Times reports that Merck would pay $107 per American Depositary Share (ADS), sig...